Correlation Between Acumen Pharmaceuticals and Mersana Therapeutics
Can any of the company-specific risk be diversified away by investing in both Acumen Pharmaceuticals and Mersana Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acumen Pharmaceuticals and Mersana Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Acumen Pharmaceuticals and Mersana Therapeutics, you can compare the effects of market volatilities on Acumen Pharmaceuticals and Mersana Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acumen Pharmaceuticals with a short position of Mersana Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acumen Pharmaceuticals and Mersana Therapeutics.
Diversification Opportunities for Acumen Pharmaceuticals and Mersana Therapeutics
0.71 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Acumen and Mersana is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding Acumen Pharmaceuticals and Mersana Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mersana Therapeutics and Acumen Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acumen Pharmaceuticals are associated (or correlated) with Mersana Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mersana Therapeutics has no effect on the direction of Acumen Pharmaceuticals i.e., Acumen Pharmaceuticals and Mersana Therapeutics go up and down completely randomly.
Pair Corralation between Acumen Pharmaceuticals and Mersana Therapeutics
Given the investment horizon of 90 days Acumen Pharmaceuticals is expected to generate 0.31 times more return on investment than Mersana Therapeutics. However, Acumen Pharmaceuticals is 3.18 times less risky than Mersana Therapeutics. It trades about -0.2 of its potential returns per unit of risk. Mersana Therapeutics is currently generating about -0.24 per unit of risk. If you would invest 185.00 in Acumen Pharmaceuticals on November 2, 2024 and sell it today you would lose (29.00) from holding Acumen Pharmaceuticals or give up 15.68% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Acumen Pharmaceuticals vs. Mersana Therapeutics
Performance |
| Timeline |
| Acumen Pharmaceuticals |
| Mersana Therapeutics |
Acumen Pharmaceuticals and Mersana Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Acumen Pharmaceuticals and Mersana Therapeutics
The main advantage of trading using opposite Acumen Pharmaceuticals and Mersana Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acumen Pharmaceuticals position performs unexpectedly, Mersana Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mersana Therapeutics will offset losses from the drop in Mersana Therapeutics' long position.| Acumen Pharmaceuticals vs. Surrozen | Acumen Pharmaceuticals vs. Armata Pharmaceuticals | Acumen Pharmaceuticals vs. Pasithea Therapeutics Corp | Acumen Pharmaceuticals vs. Aditxt Inc |
| Mersana Therapeutics vs. Terns Pharmaceuticals | Mersana Therapeutics vs. Amylyx Pharmaceuticals | Mersana Therapeutics vs. Acumen Pharmaceuticals | Mersana Therapeutics vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |